Medtronic Stock Forecast, Price & News

Medtronic (NYSE:MDT) Frequently Asked Questions

Is Medtronic a buy right now?

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 9 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic or view top-rated stocks.

How has Medtronic's stock been impacted by Coronavirus (COVID-19)?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MDT shares have increased by 12.7% and is now trading at $104.21.
View which stocks have been most impacted by COVID-19.

Are investors shorting Medtronic?

Medtronic saw a increase in short interest in December. As of December 31st, there was short interest totaling 11,660,000 shares, an increase of 19.2% from the December 15th total of 9,780,000 shares. Based on an average daily volume of 6,620,000 shares, the short-interest ratio is presently 1.8 days. Currently, 0.9% of the company's stock are short sold.
View Medtronic's Short Interest.

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Medtronic.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) released its quarterly earnings results on Tuesday, November, 23rd. The medical technology company reported $1.32 earnings per share for the quarter, beating analysts' consensus estimates of $1.29 by $0.03. The medical technology company had revenue of $7.85 billion for the quarter, compared to the consensus estimate of $7.98 billion. Medtronic had a net margin of 14.80% and a trailing twelve-month return on equity of 14.52%. The company's quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the company posted $1.02 earnings per share.
View Medtronic's earnings history.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Friday, December 10th. Investors of record on Wednesday, December 22nd will be paid a dividend of $0.63 per share on Friday, January 14th. This represents a $2.52 annualized dividend and a dividend yield of 2.42%. The ex-dividend date is Tuesday, December 21st.
View Medtronic's dividend history.

Is Medtronic a good dividend stock?

Medtronic pays an annual dividend of $2.52 per share and currently has a dividend yield of 2.39%. Medtronic has been increasing its dividend for 45 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Medtronic is 72.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Medtronic will have a dividend payout ratio of 40.98% next year. This indicates that Medtronic will be able to sustain or increase its dividend.
View Medtronic's dividend history.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic issued an update on its FY 2022 earnings guidance on Tuesday, December, 7th. The company provided earnings per share guidance of $5.650-$5.750 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.710. The company issued revenue guidance of -.

What price target have analysts set for MDT?

22 brokers have issued twelve-month price targets for Medtronic's stock. Their forecasts range from $104.00 to $165.00. On average, they expect Medtronic's share price to reach $131.62 in the next year. This suggests a possible upside of 26.3% from the stock's current price.
View analysts' price targets for Medtronic or view top-rated stocks among Wall Street analysts.

Who are Medtronic's key executives?

Medtronic's management team includes the following people:

• Geoffrey Straub Martha, Chairman & Chief Executive Officer
• Gregory L. Smith, Executive VP-Global Operations & Supply Chain
• Karen L. Parkhill, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
• Richard E. Kuntz, Chief Medical & Scientific Officer, Senior VP
• Laura Mauri, Chief Clinical & Regulatory Officer, Senior VP

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic CEO Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among Medtronic's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Medtronic's key competitors?

Some companies that are related to Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), STERIS (STE), Hologic (HOLX), Insulet (PODD), Teleflex (TFX) and Abiomed (ABMD).
View all of MDT's competitors.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a number of retail and institutional investors. Top institutional investors include Nordea Investment Management AB (0.73%), Coho Partners Ltd. (0.12%), New York State Teachers Retirement System (0.12%), Russell Investments Group Ltd. (0.11%), M&G Investment Management Ltd. (0.09%) and Strs Ohio (0.08%). Company insiders that own Medtronic stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Omar Ishrak, Richard H Anderson, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends for Medtronic.

Which institutional investors are selling Medtronic stock?

MDT stock was sold by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., Coho Partners Ltd., Stock Yards Bank & Trust Co., Ferguson Wellman Capital Management Inc., Chemung Canal Trust Co., Moody National Bank Trust Division, Russell Investments Group Ltd., and AustralianSuper Pty Ltd. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Brett A Wall, Geoffrey Martha, John R Liddicoat, Karen L Parkhill, Robert John White, and Sean Salmon.
View insider buying and selling activity for Medtronic or view top insider-selling stocks.

Which institutional investors are buying Medtronic stock?

MDT stock was acquired by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Gulf International Bank UK Ltd, National Bank of Canada FI, Gradient Investments LLC, LVM Capital Management Ltd. MI, Cohen Klingenstein LLC, Strs Ohio, and Professional Advisory Services Inc.. Company insiders that have bought Medtronic stock in the last two years include Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic or or view top insider-buying stocks.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $104.21.

How much money does Medtronic make?

Medtronic has a market capitalization of $140.12 billion and generates $30.12 billion in revenue each year. The medical technology company earns $3.61 billion in net income (profit) each year or $3.47 on an earnings per share basis.

How many employees does Medtronic have?

Medtronic employs 90,000 workers across the globe.

When was Medtronic founded?

Medtronic was founded in 1949.

What is Medtronic's official website?

The official website for Medtronic is www.medtronic.com.

Where are Medtronic's headquarters?

Medtronic is headquartered at 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at (531) 438-1700, via email at [email protected], or via fax at 763-514-4879.